Gregory G. Stone

Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial

Antoní Torres, Nanshan Zhong, Jan Pachl et al. · The Lancet Infectious Diseases · 2017 · 443 citations

Medicine, Clinical Sciences, Infectious Diseases +17

The Arginine Catabolic Mobile Element and Staphylococcal Chromosomal Cassette<i>mec</i>Linkage: Convergence of Virulence and Resistance in the USA300 Clone of Methicillin‐Resistant<i>Staphylococcus aureus</i>

Binh An Diep, Gregory G. Stone, Li Basuino et al. · The Journal of Infectious Diseases · 2008 · 420 citations · Full text

Life Sciences, Microbiology, Molecular Genetics +17

Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program

Florian Wagenlehner, Jack D. Sobel, Paul Newell et al. · Clinical Infectious Diseases · 2016 · 352 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Detection of Salmonella serovars from clinical samples by enrichment broth cultivation-PCR procedure

Gregory G. Stone, Richard D. Oberst, Michael P. Hays et al. · Journal of Clinical Microbiology · 1994 · 189 citations · Full text

Life Sciences, Microbiology, Molecular Biology +11

A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori

Gregory G. Stone, Dee Shortridge, James Versalovic et al. · Antimicrobial Agents and Chemotherapy · 1997 · 163 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17